Ten pitfalls in the proper management of patients with hyponatremia

  title={Ten pitfalls in the proper management of patients with hyponatremia},
  author={Theodosios D. Filippatos and George Liamis and Moses S. Elisaf},
  journal={Postgraduate Medicine},
  pages={516 - 522}
ABSTRACT Hyponatremia (serum sodium <135 mEq/L) is a common electrolyte disorder in community or hospitalized patients. Serum sodium levels should be corrected at a proper rate in patients with hyponatremia, since overcorrection of serum sodium levels is related to devastating neurologic consequences, such as the osmotic demyelination syndrome (ODS). However, a number of pitfalls, which could lead to undercorrection or overcorrection of hyponatremia, are common during the treatment of… 
Pharmacological management of hyponatremia
The efficacy and side effects of the currently available treatment options for hyponatremia and the differences in the pharmacological approach between the European and USA guidelines are discussed.
Hyponatremia in Patients with Hematologic Diseases
This review describes the pathophysiology of hyponatremia and discusses thoroughly the contributing factors and mechanisms that may be encountered specifically in patients with hematologic disorders.
Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial
In treating patients with symptomatic hyponatremia, individuals with high hypon atremia overcorrection risks were predictable using a novel risk score summarizing baseline information.
MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment.
The main mechanism for the development of hyponatremia in patients with chronic hypothyroidism is the decreased capacity of free water excretion due to elevated antidiuretic hormone levels, which is mainly attributed to the hyp Timothyroidism-induced decrease in cardiac output.
Frequency of hyponatremia and its outcome in critically ill patients
More than one-third of critically ill patients had hyponatremia and it was related to poor outcome of the critically ill Patients admitted in the Department of Critical Care Medicine, BIRDEM General Hospital.
Electrolyte and Acid–Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach
Electrolyte and acid–base disturbances are frequent in patients with end-stage liver disease; the underlying physiopathological mechanisms are often complex and represent a diagnostic and therapeutic
Use of intravenous fluids/solutions: a narrative review
Clinical studies have not shown a greater clinical benefit of albumin solutions compared with crystalloid solutions, and intravenous fluids should be dealt with as drugs, as they have specific clinical indications, contraindications and adverse effects.
Acid-base and electrolyte disorders associated with the use of antidiabetic drugs
Clinicians should choose appropriately between antidiabetic drugs based not only on their hypoglycemic efficacy and effects on cardiovascular risk but also based on the patient’s specific risk to develop acid-base or electrolyte derangements.
Efficacy of Furosemide, Oral Sodium Chloride, and Fluid Restriction for Treatment of Syndrome of Inappropriate Antidiuresis (SIAD): An Open-label Randomized Controlled Study (The EFFUSE-FLUID Trial).
In patients with SIAD, furosemide with NaCl supplement in combination with fluid restriction did not show benefits in correction of [Na+] compared with treatment withfluid restriction alone.
Contribution à l'étude du rôle de l’hyponatrémie légère et chronique dans la survenue de la chute grave du sujet âgé fragile admis en unité de Médecine d'Urgence de la Personne Agée (MUPA)
Les chutes a domicile sont un signe precurseur de la perte d’autonomie et representent un probleme majeur de sante publique. La chute implique de multiples facteurs determinant le risque de chute.


Role of vaptans in the management of hyponatremia.
Vaptans have been shown to increase serum sodium concentrations in patients with euvolemic or hypervolemic hyponatremia in a reproducible manner, but their safe use requires full understanding of their indications and contraindications.
The challenge of hyponatremia.
A diagnostic evaluation directed at the pathogenesis and putative causes of hyponatremia, the case-specific clinical and laboratory features, and the associated clinical risk; and a management plan tailored to the diagnostic findings that incorporates quantitative projections of fluid therapy and fluid losses on the patient's serum sodium are presented.
The hyponatremic patient: a systematic approach to laboratory diagnosis.
Levels of hormones (thyroid-stimulating hormone and cortisol) and arterial blood gases should be determined in difficult cases of hyponatremia and in patients with normal or elevated effective serum osmolality in the hypo-osmolar state.
Evaluation and management of hypo-osmolality in hospitalized patients.
Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Combined 3% saline solution and desmopressin appears to be a valid strategy for correcting severe hyponatremia, but studies comparing the regimen with other therapeutic strategies are needed.
Therapeutic approach in patients with dysnatraemias.
The formula that has been proposed by Adrogue and Madias predicted with relative accuracy the changes in serum sodium concentration in almost all patients and should be considered as a very useful tool for the management of dysnatraemias.
Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
No significant differences were identified in adherence to treatment guidelines and neither agent poses a significant risk of over-correction at 4, 24, or 48 hours of therapy, based on this small retrospective study.
A review of drug-induced hyponatremia.
Clinical information about the incidence of hyponatremia associated with specific drug treatment is reviewed and the underlying pathophysiologic mechanisms are discussed.